Dr. James P. Evans
James P. Evans, M.D., Ph.D. is
Editor-in-Chief of
Genetics in Medicine and
Professor of Genetics and Medicine,
University of North Carolina at Chapel Hill. He is also Director of
UNC Clinical Cancer Genetics Services and of the UNC Bryson
Program in Human Genetics.
Jim is interested in cancer genetics, pharmacogenomics, and the
broad issue of the use of genetic information. He is an advisor to the
US Secretary of Health and Human Services on the subject of “Genetics,
Health, and Society”. He has been actively involved nationally and
internationally in education of high courts about genetic and scientific
matters. In 2004 he was a principle organizer and faculty member for a
United Nations conference in Chile which was attended by over 80 nations
and addressed scientific disparities throughout the world.
Jim is:
Conversant on medical and cancer genetics, disease causation
and genetics, medical decision making, and biotechnology.
Directs the Carolina Center for Genome Sciences’ Clinical
Cancer Genetics Services, which evaluates and counsels patients who are
perceived to be at high risk for cancer by virtue of their family
history.
Directs the new UNC Bryson Program in Human Genetics, which
seeks to integrate basic science investigation with clinical care.
Involved in the campus-wide “Phenotyping Core” which serves to
collect DNA samples and clinical information from a broad array of
investigators in order to gain maximal amounts of information from
genetic studies and facilitate such studies.
Organizer and participant in recent United Nations conference
in Concepcin, Chile that addressed transnational discrepancies in the
development and application of biotechnology.
Senior scientific advisor to the Einstein Institute for
Science, Health, and the Courts, an organization that has been
instrumental in educating high court judges in matters of genetics and
biotechnology.
Jim authored
The complexities of predictive genetic testing,
Physical mapping of the split hand/split foot locus on chromosome 7
and
implication in syndromic ectrodactyly,
A germline substitution in the human MSH2 gene is associated with
high-grade dysplasia and cancer in ulcerative colitis,
The new genetics and its consequences for family, kinship, medicine
and
medical genetics,
Racial Differences in Enrollment in a Cancer Genetics
Registry,
Asp187Asn mutation of gelsolin in an American kindred with familial
amyloidosis, Finnish type (FAP IV), and
Canine hemophilia B resulting from a point mutation with unusual
consequences.
Jim earned his
Ph.D. in Pathology and Oncology in 1983 and his M.D. in 1984, both from
the
University of Kansas Medical Center Graduate
School. He served
as resident and chief resident of Internal Medicine at The University of
North Carolina. He trained in medical genetics at The University of
Washington in Seattle before moving back to Chapel Hill. He is board
certified in Internal Medicine, Medical Genetics, and in Molecular
Diagnostics.
Read
Biologist Teaches the Nation’s Judges About
Genetics.
